vs
Cytek Biosciences, Inc.(CTKB)与Resolute Holdings Management, Inc.(RHLD)财务数据对比。点击上方公司名可切换其他公司
Resolute Holdings Management, Inc.的季度营收约是Cytek Biosciences, Inc.的1.9倍($117.7M vs $62.1M),Resolute Holdings Management, Inc.净利率更高(-1.5% vs -70.9%,领先69.5%),Resolute Holdings Management, Inc.自由现金流更多($189.2M vs $-1.8M)
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化,产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域,客户遍及全球多个主要地区。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业,核心业务布局于非洲地区,目前运营两座金矿,分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿,专注于黄金资源的勘探、开采及相关运营管理工作。
CTKB vs RHLD — 直观对比
营收规模更大
RHLD
是对方的1.9倍
$62.1M
净利率更高
RHLD
高出69.5%
-70.9%
自由现金流更多
RHLD
多$191.0M
$-1.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $62.1M | $117.7M |
| 净利润 | $-44.1M | $-1.7M |
| 毛利率 | 52.9% | 55.7% |
| 营业利润率 | -9.0% | 30.2% |
| 净利率 | -70.9% | -1.5% |
| 营收同比 | 8.1% | — |
| 净利润同比 | -557.1% | — |
| 每股收益(稀释后) | — | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CTKB
RHLD
| Q4 25 | $62.1M | $117.7M | ||
| Q3 25 | $52.3M | $120.9M | ||
| Q2 25 | $45.6M | $119.6M | ||
| Q1 25 | $41.5M | $103.9M | ||
| Q4 24 | $57.5M | — | ||
| Q3 24 | $51.5M | — | ||
| Q2 24 | $46.6M | — | ||
| Q1 24 | $44.9M | — |
净利润
CTKB
RHLD
| Q4 25 | $-44.1M | $-1.7M | ||
| Q3 25 | $-5.5M | $-231.0K | ||
| Q2 25 | $-5.6M | $-611.0K | ||
| Q1 25 | $-11.4M | $-3.4M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $941.0K | — | ||
| Q2 24 | $-10.4M | — | ||
| Q1 24 | $-6.2M | — |
毛利率
CTKB
RHLD
| Q4 25 | 52.9% | 55.7% | ||
| Q3 25 | 52.7% | 59.0% | ||
| Q2 25 | 52.3% | 57.5% | ||
| Q1 25 | 48.6% | 52.5% | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率
CTKB
RHLD
| Q4 25 | -9.0% | 30.2% | ||
| Q3 25 | -17.6% | 34.3% | ||
| Q2 25 | -23.3% | 34.0% | ||
| Q1 25 | -36.1% | 24.7% | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | -8.2% | — | ||
| Q2 24 | -18.3% | — | ||
| Q1 24 | -23.9% | — |
净利率
CTKB
RHLD
| Q4 25 | -70.9% | -1.5% | ||
| Q3 25 | -10.5% | -0.2% | ||
| Q2 25 | -12.2% | -0.5% | ||
| Q1 25 | -27.5% | -3.2% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | -22.4% | — | ||
| Q1 24 | -13.8% | — |
每股收益(稀释后)
CTKB
RHLD
| Q4 25 | — | $-0.20 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.39 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $341.7M | $6.5M |
| 总资产 | $461.5M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势,按日历期对齐
现金及短期投资
CTKB
RHLD
| Q4 25 | $90.9M | $205.5M | ||
| Q3 25 | $93.3M | $148.0M | ||
| Q2 25 | $75.5M | $99.9M | ||
| Q1 25 | $95.3M | $71.0M | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
总债务
CTKB
RHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
CTKB
RHLD
| Q4 25 | $341.7M | $6.5M | ||
| Q3 25 | $378.6M | $10.8M | ||
| Q2 25 | $377.6M | $9.6M | ||
| Q1 25 | $379.6M | $8.9M | ||
| Q4 24 | $395.7M | — | ||
| Q3 24 | $385.5M | — | ||
| Q2 24 | $389.1M | — | ||
| Q1 24 | $392.6M | — |
总资产
CTKB
RHLD
| Q4 25 | $461.5M | $333.4M | ||
| Q3 25 | $494.9M | $293.2M | ||
| Q2 25 | $493.3M | $253.3M | ||
| Q1 25 | $482.6M | $214.3M | ||
| Q4 24 | $499.5M | — | ||
| Q3 24 | $491.2M | — | ||
| Q2 24 | $483.7M | — | ||
| Q1 24 | $492.1M | — |
负债/权益比
CTKB
RHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $189.2M |
| 自由现金流率自由现金流/营收 | -2.9% | 160.8% |
| 资本支出强度资本支出/营收 | 1.6% | 5.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $313.2M |
8季度趋势,按日历期对齐
经营现金流
CTKB
RHLD
| Q4 25 | $-771.0K | $196.1M | ||
| Q3 25 | $-3.9M | $59.6M | ||
| Q2 25 | $108.0K | $48.9M | ||
| Q1 25 | $-125.0K | $18.4M | ||
| Q4 24 | $2.0M | — | ||
| Q3 24 | $13.2M | — | ||
| Q2 24 | $6.2M | — | ||
| Q1 24 | $4.0M | — |
自由现金流
CTKB
RHLD
| Q4 25 | $-1.8M | $189.2M | ||
| Q3 25 | $-4.6M | $58.6M | ||
| Q2 25 | $-1.5M | $47.5M | ||
| Q1 25 | $-974.0K | $17.8M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
自由现金流率
CTKB
RHLD
| Q4 25 | -2.9% | 160.8% | ||
| Q3 25 | -8.7% | 48.5% | ||
| Q2 25 | -3.2% | 39.7% | ||
| Q1 25 | -2.3% | 17.1% | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
资本支出强度
CTKB
RHLD
| Q4 25 | 1.6% | 5.8% | ||
| Q3 25 | 1.3% | 0.8% | ||
| Q2 25 | 3.5% | 1.2% | ||
| Q1 25 | 2.0% | 0.6% | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
现金转化率
CTKB
RHLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
RHLD
暂无分部数据